Peter R. Breggin, MD, has been called “the conscience of psychiatry” for his efforts to reform the mental health field, including his promotion of caring psychotherapeutic approaches and his opposition to the escalating overuse of psychiatric medications, the oppressive diagnosing and drugging of children, electroshock, lobotomy, involuntary treatment, and false biological theories.
A Harvard-trained psychiatrist and former full-time consultant at NIMH, Dr. Breggin’s private practice is in Ithaca, New York, where he treats adults, couples, and families with children. He also offers consultations in clinical psychopharmacology and often acts as a medical expert in criminal, malpractice and product liability suits. He is the author of many scientific articles and books including Medication Madness: A psychiatrist exposes the dangers of mood-altering medications (2008).
More information on Dr. Breggin is available on this site here.
What you may need to know about:
- Psychiatric drug adverse reactions (side effects) and medication spellbinding
- Violence and suicide caused by antidepressants
- Mental dysfunction and addiction caused by benzodiazepines
- Tardive dyskinesia (TD) caused by antipsychotic drugs
- Children, ADHD and stimulant drugs
- The hazards of electroshock and psychosurgery
- Psychiatric drug dependence (addiction) and withdrawal reactions
- FDA actions and shortcomings
- Legal cases: criminal, malpractice and product liability suits involving antidepressants, tranquilizers, antipsychotic drugs, mood stabilizers, stimulants, children and ADHD, electroshock (ECT), and psychosurgery
Since the early 1970s, Dr. Peter Breggin has been active as a medical expert in malpractice and product liability suits, as well as criminal cases in which psychiatric or psychoactive drugs have contributed to abnormal behavior. He has also testified in cases involving involuntary treatment, electroshock treatment, and psychosurgery. He has testified more than 70 times in court.
This website may contain some copyrighted material. We reserve the right to reproduce such material under the Copyright Act, Title 17 US Code, Section 107, “Fair Use”, as we believe the public should be informed of such information so they can think for themselves rather than rely on advertisements. We gain no profit from such articles. http://www.copyright.gov/title17/92chap1.html#107